Celanese (CE) to Promote VitalDose EVA at CRS Annual Meet

Celanese Corporation CE will feature VitalDose ethylene vinyl acetate EVA, a versatile polymer used in delivering controlled release medications with varying routes of administration including subcutaneous drug delivery implants at the 2016 Controlled Release Society CRS Annual Meeting and Exposition, from Jul 17–20 in Seattle, WA.

Celanese VitalDose EVA, a controlled release material, is meeting the increasing needs of the industry as pharmaceutical companies are searching for better administrative methods to boost efficacy and improve patient drug compliance. It helps manufacturers derive a polymer as per their needs, which would provide them the flexibility to develop controlled release devices that can be used for external or subcutaneous applications.

VitalDose EVA allows manufacturers to customize the release rate of drugs used in implantable drug delivery devices. This copolymer, which blends soundly with other polymers, can be used alone as well as with other excipients or additives to attain the required release rate. VitalDose EVA is used by pharmaceutical companies in a large range of drug delivery applications such as transdermal, subcutaneous, ocular, intravaginal, intraoral and rectal.

Celanese's shares rose 2.8% to close at $67.14 on Jul 8.

CELANESE CP-A Price

CELANESE CP-A Price | CELANESE CP-A Quote

Celanese's adjusted earnings for first-quarter 2016 were $1.83 per share, indicating a 6% increase from the prior-year quarter. Earnings per share also beat the Zacks Consensus Estimate of $1.52. Although revenues dropped roughly 3% year over year to $1,404 million in the quarter, the figure beat the Zacks Consensus Estimate.

Celanese also upgraded its outlook for 2016. It now expects an improvement of 8%−10% in earnings per share, compared to 5%−10% growth stated earlier. The company intends to pursue commercial discipline coupled with excellence in operation and productivity, to survive and grow in the current environment.

Celanese currently carries a Zacks Rank #3 (Hold).

Better-ranked companies in the chemicals industry include Axiall Corporation AXLL, Albemarle Corporation ALB and Asahi Kasei Corp. AHKSY, all sporting a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>